From ex vivo manufacturing to in vivo CAR-T therapy (IMAGE)

Immunity & Inflammation

From ex vivo manufacturing to in vivo CAR-T therapy

Caption

Targeted delivery systems enable T cells to be genetically reprogrammed directly inside the body, offering a potential alternative to conventional ex vivo CAR-T manufacturing.

Credit

"Cancer Immunotherapy" by National Institutes of Health (NIH) from Openverse Image source link: https://openverse.org/image/6cb65b79-cbdc-4198-b3f4-30a65dcffd25?q=T+cell+cancer+immunotherapy&p=2

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted.

License

CC BY-NC

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.